Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

May 29 • 04:00PM ET

73.50

+1.39 1.93 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB IWO VTWO SCHA IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	11.01%	Shs Outstand	78.84M	Perf Week	-1.10%
Market Cap	6.38B	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-2.83%	Shs Float	77.28M	Perf Month	2.24%
Enterprise Value	5.80B	PEG	-	EPS next Q	-0.73	Inst Own	87.14%	Short Float	16.07%	Perf Quarter	70.89%
Income	-168.74M	P/S	-	EPS this Y	-47.69%	Inst Trans	1.13%	Short Ratio	11.37	Perf Half Y	151.71%
Sales	0.00M	P/B	11.25	EPS next Y	-7.78%	ROA	-25.30%	Short Interest	12.42M	Perf YTD	124.36%
Book/sh	6.53	P/C	8.61	EPS next 5Y	-21.87%	ROE	-29.26%	52W High	78.80 -6.73%	Perf Year	372.67%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 427.63%	Perf 3Y	2074.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.82% 5.59%	Perf 5Y	-55.52%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	3.98	Perf 10Y	-59.39%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	56.41	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	0.84%	Beta	3.06	Target Price	95.20
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	14.96%	Rel Volume	0.96	Prev Close	72.11
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	100.83%	Avg Volume	1.09M	Price	73.50
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	1,051,106	Change	1.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)